Ticker
CTXR
Analysis
Citius Pharmaceuticals, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to CTXR.
Citius Pharmaceuticals, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to CTXR.
CTXR
Stock
$15.0M
Health Technology
Medical Specialties
USD
Citius Pharmaceuticals, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
Citius Oncology Highlights Phase 1 Data in an Investigator-Initiated Study of LYMPHIR® (denileukin diftitox-cxdl) in Combination with Pembrolizumab in Recurrent or Refractory Gy...
Citius Oncology Announces Presentation of LYMPHIR® Phase 1 Combination Study Data at the 2026 American Society of Clinical Oncology Annual
Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR), a biopharmaceutical company dedicated to the development and commercialization of first-in-class ...
Avenue Capital Group to provide up to $25 Million via Senior Credit Facility with an initial $10 million tranche funded at closing; additional tranches
Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), an oncology‑focused biopharmaceutical company and majority‑owned subsidiary of Citius Pharmaceuticals, Inc. ("Citius Ph...
Review valuation context for Citius Pharmaceuticals, Inc..
Review future growth context for Citius Pharmaceuticals, Inc..
Review past performance context for Citius Pharmaceuticals, Inc..
Review financial health context for Citius Pharmaceuticals, Inc..
Review dividend context for Citius Pharmaceuticals, Inc..
Review management context for Citius Pharmaceuticals, Inc..
Review ownership context for Citius Pharmaceuticals, Inc..
Review other information context for Citius Pharmaceuticals, Inc..
Review community context for Citius Pharmaceuticals, Inc..